
News|Articles|May 9, 2024
Pharmacogenomics: Sticking to the Evidence Base
Author(s)John J. Miller, MD
Pharmacogenomics at the 2024 APA Annual Meeting.
Advertisement
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John. J. Miller, MD, sat down with us at the 2024 American Psychiatric Association Annual Meeting to discuss pharmacogenomics, a topic he is very passionate about.
Dr Miller is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times; Staff Psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
New Name, New Path for Psychiatry: The Future of the DSM
4
Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy
5







